Additional information was received for h3, h4, h6, and h10.H4: device manufacture date: the lot was manufactured from september 2, 2022 to september 7, 2022.H10: the actual device was returned for evaluation.Visual inspection did not identify any abnormalities that could have contributed to the reported flow problem.A functional flow rate test was performed, and the flow rates were observed to be within the product specification range.No evidence of rupture was observed from the bladder during visual inspection and flow test.The reported condition of underinfusion was not verified.The reported condition of rupture was not verified.The returned sample was determined to be a conforming product.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|